NASDAQ:FLXN
Delisted
Flexion Therapeutics Stock News
$9.12
+0 (+0%)
At Close: May 27, 2022
Flexion Therapeutics Announces ZILRETTA License Agreement; Co. To Receive Upfront Payment Of $10M, Up To $32.5M In Milestones
12:00am, Wednesday, 01'st Apr 2020Flexion Therapeutics (NASDAQ:FLXN) Rating Increased to Sell at BidaskClub
06:16am, Sunday, 29'th Mar 2020
Flexion Therapeutics (NASDAQ:FLXN) was upgraded by stock analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued on Friday, BidAskClub reports. FLXN h
Edited Transcript of XENE earnings conference call or presentation 9-Mar-20 8:30pm GMT
03:39am, Friday, 27'th Mar 2020
Q4 2019 Xenon Pharmaceuticals Inc Earnings Call
Flexion Therapeutics (FLXN) Receives a Buy from RBC Capital
02:39pm, Wednesday, 25'th Mar 2020
In a report released today, Randall Stanicky from RBC Capital reiterated a Buy rating on Flexion Therapeutics (FLXN), with a price target of $20.00. The
Flexion Therapeutics (FLXN) Receives a Buy from RBC Capital
02:39pm, Wednesday, 25'th Mar 2020
In a report released today, Randall Stanicky from RBC Capital reiterated a Buy rating on Flexion Therapeutics (FLXN – Research
Flexion Therapeutics: Reporting Record Revenue On A Record Day For The Market
03:00pm, Thursday, 19'th Mar 2020
Flexion reported positive Q4/2019 earnings in the midst of the Coronavirus Crash. The stock has taken a nosedive to all-time lows and I am looking to take advan
Flexion Therapeutics (NASDAQ:FLXN) Shares Up 9.1%
08:02am, Thursday, 19'th Mar 2020
Flexion Therapeutics Inc (NASDAQ:FLXN)’s stock price shot up 9.1% during mid-day trading on Tuesday . The stock traded as high as $7.46 and last traded at $7.20, 2,041,823 shares traded hands during
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Upside For Flexion Therapeutics Depends On How Well It Can Commercialize ZILRETTA In 2020
01:21pm, Wednesday, 18'th Mar 2020
ZILRETTA sales appear to be plateauing given Q4 2020 revenue. ZILRETTA's label change on its face doesn't appear very helpful, but may drive sales based on deep
Edited Transcript of FLXN earnings conference call or presentation 12-Mar-20 8:30pm GMT
07:49pm, Monday, 16'th Mar 2020
Q4 2019 Flexion Therapeutics Inc Earnings Call
Flexion Therapeutics, Inc. Just Released Its Full-Year Results And Analysts Are Updating Their Estimates
12:55pm, Saturday, 14'th Mar 2020
One of the biggest stories of last week was how Flexion Therapeutics, Inc. (NASDAQ:FLXN) shares plunged 33% in the...
Flexion Therapeutics, Inc. (NASDAQ:FLXN): What Does Its Beta Value Mean For Your Portfolio?
07:07pm, Friday, 13'th Mar 2020
If you own shares in Flexion Therapeutics, Inc. (NASDAQ:FLXN) then it's worth thinking about how it contributes to the...
Flexion Therapeutics Inc (FLXN) Q4 2019 Earnings Call Transcript
04:30pm, Friday, 13'th Mar 2020
FLXN earnings call for the period ending December 31, 2019.
Flexion Therapeutics (FLXN) Gets a Buy Rating from Needham
10:28am, Friday, 13'th Mar 2020
Needham analyst Serge Belanger maintained a Buy rating on Flexion Therapeutics (FLXN) today and set a price target of $36.00. The company's shares closed
Flexion Therapeutics (FLXN) Gets a Buy Rating from Needham
10:28am, Friday, 13'th Mar 2020
Needham analyst Serge Belanger maintained a Buy rating on Flexion Therapeutics (FLXN – Research Report) today and set a price
